"Sarcoidosis, Pulmonary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Sarcoidosis affecting predominantly the lungs, the site most frequently involved and most commonly causing morbidity and mortality in sarcoidosis. Pulmonary sarcoidosis is characterized by sharply circumscribed granulomas in the alveolar, bronchial, and vascular walls, composed of tightly packed cells derived from the mononuclear phagocyte system. The clinical symptoms when present are dyspnea upon exertion, nonproductive cough, and wheezing. (Cecil Textbook of Medicine, 19th ed, p431)
| Descriptor ID |
D017565
|
| MeSH Number(s) |
C08.381.483.725 C15.604.515.827.725
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Sarcoidosis, Pulmonary".
Below are MeSH descriptors whose meaning is more specific than "Sarcoidosis, Pulmonary".
This graph shows the total number of publications written about "Sarcoidosis, Pulmonary" by people in this website by year, and whether "Sarcoidosis, Pulmonary" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2016 | 5 | 0 | 5 |
| 2017 | 11 | 0 | 11 |
| 2018 | 8 | 5 | 13 |
| 2019 | 4 | 1 | 5 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Sarcoidosis, Pulmonary" by people in Profiles.
-
Outcomes of SARS-CoV-2 infection in patients with pulmonary sarcoidosis: A multicenter retrospective research network study. Respir Med. 2021 10; 187:106538.
-
Moderate or Severe Impairment in Pulmonary Function is Associated with Mortality in Sarcoidosis Patients Infected with SARS-CoV-2. Lung. 2020 10; 198(5):771-775.
-
Management of Immunosuppression During Severe COVID-19 Infection in a Patient With Pulmonary and Cardiac Sarcoidosis. J Clin Rheumatol. 2020 Sep; 26(6):229-232.
-
COVID-19 in Patient with Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020. Emerg Infect Dis. 2020 Oct; 26(10):2513-2515.
-
Coronavirus Disease 2019 Suspicion: A Case Report Regarding a Male Emergency Medical Service Pilot With Newly Diagnosed Sarcoidosis. Air Med J. 2020 Jul - Aug; 39(4):296-297.
-
Doxycycline treatment of high-risk COVID-19-positive patients with comorbid pulmonary disease. Ther Adv Respir Dis. 2020 Jan-Dec; 14:1753466620951053.
-
SARS-CoV-2 lung disease in a patient with pulmonary sarcoidosis - case report. Adv Respir Med. 2020; 88(6):620-625.
-
Clinical differences in sarcoidosis patients with and without lymphoma: a single-centre retrospective cohort analysis. Eur Respir J. 2019 11; 54(5).
-
Musculoskeletal and pulmonary outcomes of sarcoidosis after initial presentation of osseous involvement. Sarcoidosis Vasc Diffuse Lung Dis. 2019; 36(1):60-73.
-
The composition of the pulmonary microbiota in sarcoidosis - an observational study. Respir Res. 2019 Feb 28; 20(1):46.